Literature DB >> 31874260

Metabolic syndrome after Roux-en-Y gastric bypass in patients with morbid obesity: Five years of follow-up, a before and after study.

Cristobalina Rodríguez-Álvarez1, Alfonso Orelve Acosta-Torrecilla1, Enrique González-Dávila2, Ángeles Arias3.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is common among morbidly obese patients undergoing bariatric surgery. The aim of this study is to analyse prevalence and evolution of MetS in patients suffering from morbid obesity, before and after bariatric surgery, during a follow-up period of 5 years.
METHODS: A before-after study was carried out including 156 patients with MetS. The definition of metabolic syndrome according to the Joint Interim Statement (JIS) definition was used. Demographic, as well as anthropometric, biochemical, and clinical analyses were assessed before, as well as 2 and 5 years after performing laparoscopic Roux-en-Y gastric bypass (RYGB).
RESULTS: High BMI (100%), elevated blood pressure (78%) and low levels of high density lipoprotein (70%) were the most prevalent criteria for MetS. The percentage of people with MetS decreased significantly to 48.9% at 2 years and 24.1% at 5 years. The weight was also significantly reduced at 2 years, although at 5 years a rebound effect is already observed. Percentage of total weight loss (%TWL) and excess BMI loss (%EBMIL) were. 49.7 ± 19.4% and 68.2 ± 18.9%, respectively, at 2 years and 29.3 ± 11.6% and 62.0 ± 24.9 at 5 years, both presenting significant differences (p < 0.001).
CONCLUSION: RYGB in obese patients is associated with a significant improvement of MetS and its comorbidities. Insufficient weight loss is the main factor related to the prevalence of MetS.
Copyright © 2019 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Before-after study; Laparoscopic gastric bypass; Metabolic syndrome; Morbid obesity

Mesh:

Year:  2019        PMID: 31874260     DOI: 10.1016/j.ijsu.2019.12.019

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  4 in total

1.  Arterial Hypertension in Morbid Obesity after Bariatric Surgery: Five Years of Follow-Up, a Before-And-After Study.

Authors:  Angeles Arias; Cristobalina Rodríguez-Álvarez; Enrique González-Dávila; Alfonso Acosta-Torrecilla; M Mercedes Novo-Muñoz; Natalia Rodríguez-Novo
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

2.  Concordance between Different Criteria for Metabolic Syndrome in Peruvian Adults Undergoing Bariatric Surgery.

Authors:  Nataly Echevarria-Castro; Kevin Silva-Parra; Marcos Polar-Trinidad; Juan C Sánchez-Vicente; Gustavo Salinas-Sedo; Carlos J Toro-Huamanchumo
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

3.  The Effect of Bariatric Surgery on Metabolic Syndrome: A Three-center Experience in Saudi Arabia.

Authors:  Abdulrahman O Alomar; Mohammed F Shaheen; Abdallh S Almaneea; Eyad K Althaqeb; Ziyad M Alshahrani; Yazeed A Jarman; Sultan Alhabdan
Journal:  Obes Surg       Date:  2021-05-27       Impact factor: 4.129

4.  The Incidence and Risk Factors of Cholelithiasis Development After Bariatric Surgery in Saudi Arabia: A Two-Center Retrospective Cohort Study.

Authors:  Mohammed A Aldriweesh; Ghadeer L Aljahdali; Edi A Shafaay; Dalal Z Alangari; Nawaf A Alhamied; Hadeel A Alradhi; Amirah S Yaqoub; Sami El-Boghdadly; Omar S Aldibasi; Abdallah A Adlan
Journal:  Front Surg       Date:  2020-10-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.